White patches, red patches and pigmented lesions Flashcards

1
Q

Reasons why oral lesions may appear white?

A

epithelium has thickened
organic material
- Candida
- food debris
physiological
- tongue coating
- desquamation
- leukoedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

White patches - potential causes (CLINK)

A

congenital
lichen planus
infections
neoplastic/potentially neoplastic
keratosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Give examples of neoplastic and potentially malignant white patches

A

squamous cell carcinoma
leukoplakia
sub mucous fibrosis
actinic chelitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Squamous cell carcinoma red flags

A

> 3 week duration
50 years old
smoking
high alcohol consumption
history of oral cancer
non-homogenous
non-healing ulceration
tooth mobility
non-healing extraction sockets
difficulty speaking or/and swallowing
weight loss
fatigue
appetite loss
cervical lymphadenopathy
numbness/altered sensation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

squamous cell carcinoma management

A

urgent suspected cancer referral to oral and maxillofacial surgery
be honest with patient and explain concern
explain that they will need to get a biopsy/sample promptly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Leukoplakia - define

A

a white patch or plaque that cannot be characterised clinically or pathologically
- can’t be rubbed away

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Leukoplakia - significance

A

2-5% become malignant in 10 years
5-20% are dysplastic
10-35% of leukoplakias showing dysplasia proceed to carcinoma in 10 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical risk factors for malignant transformation

A

strong association
size >200mm2
non homogenous texture
red or speckled colour
tongue or floor of mouth

medium association
female sex
>50 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Histological risk factors for malignant transformation

A

strong association
severe dysplasia
high risk dysplasia

medium association
HPV-16 +
many genes involved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

disorders that should be excluded for a diagnosis of leukoplakia

A

leukoedema
white sponge naeuvus
frictional keratosis
chemical injury
acute pseudomembranous candidosis
hairy leukoplakia
lichen planus (Plaque like variant)
lichenoid reaction
Discoid lupus erythematous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

proliferative verrucous leukoplakia features

A

up to 85% undergo malignant transformation
warty surface with white/yellow appearance
common sites palate and gingiva
will enlarge over time
often very extensive and impractical to remove

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

oral submucous fibrosis features

A

related to paan use
pale in colour
firm to palpate
fibrous bands develop
typically affects buccal mucosa and soft palate
mouth opening over time diminishes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

oral sub mucous fibrosis malignant transformation rate

A

5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is keratosis - name the different types/causes

A

a response to trauma
frictional
- sharp teeth/restorations/denture/occlusion
thermal
- smoking/hot foods/drink
chemical
- aspirin/acid/bleach/chlorhexixidne

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Leukoedema features

A

not a mucosal disease
normal physiology
faint white lines, typically on buccal mucosa
more common in people of African heritage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

White sponge naevus features

A

inherited autosomal dominant
mutation of genes that codes for keratins 4 and 13
affects any part of mucosa
- most commonly buccal mucosa
poorly defined border
benign

17
Q

White sponge naeuvus histology

A

hyperkeratosis
intra-cellular oedema in stratum spinosum and parakeratined layers
thickening of epithelium, especially stratum spinosum - acanthosis
no inflammatory changes

18
Q

White patches general management strategies

A

exclude red flags
does it wipe away
get photos
assess for obvious cause
refer if unsure or no improvement
biopsy?
review

19
Q

reasons why oral lesions may appear red

A

inflammation
mucosal atrophy
increased vascularisation
mucosal/submucosal bleeding

20
Q

red patches differential diagnoses and causes

A

viral infection
candida infection
iatrogenic
- mucositis secondary to chemo or radiotherapy
granulomatous disease
blistering diseases
allergy
psoriasis
geographic tongue
trauma
deficiency states
erythroplakia

21
Q

erythroplakia features

A

atrophic lesion
localised
well defined borders
can have speckled appearance - erythroleukoplakia
strong association with tobacco use
50% malignant transformation rate

22
Q

erythroplakia common sites

A

soft palate
buccal mucosa
floor or mouth

23
Q

erythroleukoplakia features

A

speckled red/white patches
heterogenous appearance
exists on a spectrum with red and white patches
highly suspicious for SSC or severe dysplasia

24
Q

red patches management

A

thorough history and examination
exclude red flags
obvious cause? correct and review
red patches have high malignant potential
biopsy if can’t be attributed to a cause

25
Q

why do lesions in the mouth appear pigmented?

A

extrinsic
- amalgam - blue grey appearance
- chlorhexidine
- tobacco
- heavy metals

intrinsic
- melanin

26
Q

peutz-jeghers syndrome features

A

developmental hypermelanosis
autosomal dominant disorder
resembled freckles - eyes mouth and nostrils
muco-cutanous pigmentation
buccal mucosa and lips affected
typically presents in infancy
- fades throughout life
GI polyposis
- gi polyps have malignancy risk

27
Q

Peutz-Jeghers syndrome investigations and management

A

FBC/endoscopy/STK11 gene
management
- manage polyps
- regular MRI/CT

28
Q

endogenous/intrinsic oral pigmentation - cause

A

inflammation
- stimulates melanocyte activity
- can be seen in lichen planus and areas of other inflammatory disease

29
Q

how does Addison’s disease lead to oral pigmentation?

A

oral pigmentation is an early presentation of Addison’s
adrenal glands no longer produce enough steroid
- adrenal insufficiency leads to increase ACTH
- ACTH causes pigmentation seen by stimulating melanocytes
- patchy hyperpigmentation can be seen

30
Q

medication associated with oral pigmentation

A

antimalarials
zidovudine
gold
heavy metals
minocycline - antibiotics
busulphan - chemotherapy

31
Q

melanotic macule features

A

single brown lesion
- comprised of a collection of melanin containing cells
flat
non raised
typically <1cm diameter
no rapid change
painless
common on vermillion border

32
Q

melanotic macule management

A

consider excisional biopsy to exclude melanoma

33
Q

melanocytic naevi features

A

medical term for a mole
blue/black lesions
focal proliferation of melanocytes
typically appear during childhood
papular appearance
typically >1cm in diameter
no rapid change
clinically resembles melanoma
- rarely progresses to melanoma

34
Q

melanoma features

A

rare
may arise from a pigmented naeuvus
palate or maxillary gingiva most common
refer if suspected melanoma

35
Q

melanoma - warning signs (ABCDE)

A

asymmetry
border irregularity
colour irregularity
diameter >6mm
evolving
- shape, size, colour, elevation

36
Q

What is a naevus?

A

a benign growth on skin caused by a cluster of melanocytes

37
Q

melanoma incidence and prevelence

A

1.2 cases per 10 million per year
1-2% of oral malignancies
average age of presentation is 60
more common in populations with higher skin pigmentation
5 year survival rate 25.5%

38
Q

Kaposi’s sarcoma features

A

vascular neoplasm/tumour
human herpes virus 8 associated
disorganised epithelial cell growth
mainly presents in immunocompromised
Reddish-blue or brown foci
can present on skin, oral mucosa or GI tract

39
Q

Kaposi’s sarcoma management

A

surgery
radiotherapy
chemotherapy
immunotherapy
managing underlying immunodeficiency